Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Professional Survey Report 2018 - 2025

Description

This report studies the global HPAPI (High Potency Active Pharmaceutical Ingredients) market status and forecast, categorizes the global HPAPI (High Potency Active Pharmaceutical Ingredients) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

High potency active pharmaceutical ingredients are used in targeted therapeutics and show effective treatment even at extremely low concentration. These APIs are difficult to manufacture and require technological expertise and sophisticated manufacturing setup. HPAPI market currently accounts for a small portion of overall API market, however is a rapidly growing segment.
The global HPAPI (High Potency Active Pharmaceutical Ingredients) market is valued at 16600 million US$ in 2017 and will reach 32200 million US$ by the end of 2025, growing at a CAGR of 8.7% during 2018-2025.

The major manufacturers covered in this report
Alkermes
Cambrex
Dishman
Dr. Reddy'S
Lonza
Novasep
Thermofisher Scientific
Pfizer
Merck
Teva Pharmaceutical

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Innovative HPAPI
Generic HPAPI

By Application, the market can be split into
Captive HPAPI
Merchant HPAPI

The study objectives of this report are:
To analyze and study the global HPAPI (High Potency Active Pharmaceutical Ingredients) capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key HPAPI (High Potency Active Pharmaceutical Ingredients) manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of HPAPI (High Potency Active Pharmaceutical Ingredients) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
HPAPI (High Potency Active Pharmaceutical Ingredients) Manufacturers
HPAPI (High Potency Active Pharmaceutical Ingredients) Distributors/Traders/Wholesalers
HPAPI (High Potency Active Pharmaceutical Ingredients) Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, We offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the HPAPI (High Potency Active Pharmaceutical Ingredients) market, by end-use.
Detailed analysis and profiles of additional market players.

TABLE OF CONTENT

Table of Contents

Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Professional Survey Report 2018
1 Industry Overview of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.1 Definition and Specifications of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.1.1 Definition of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.1.2 Specifications of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.2 Classification of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.2.1 Innovative HPAPI
1.2.2 Generic HPAPI
1.3 Applications of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.3.1 Captive HPAPI
1.3.2 Merchant HPAPI
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
2.3 Manufacturing Process Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
2.4 Industry Chain Structure of HPAPI (High Potency Active Pharmaceutical Ingredients)

3 Technical Data and Manufacturing Plants Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
3.1 Capacity and Commercial Production Date of Global HPAPI (High Potency Active Pharmaceutical Ingredients) Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global HPAPI (High Potency Active Pharmaceutical Ingredients) Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global HPAPI (High Potency Active Pharmaceutical Ingredients) Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global HPAPI (High Potency Active Pharmaceutical Ingredients) Major Manufacturers in 2017

4 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global HPAPI (High Potency Active Pharmaceutical Ingredients) Capacity and Growth Rate Analysis
4.2.2 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales and Growth Rate Analysis
4.3.2 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price
4.4.2 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis (Company Segment)

5 HPAPI (High Potency Active Pharmaceutical Ingredients) Regional Market Analysis
5.1 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
5.1.1 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
5.1.2 North America 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis
5.1.4 North America 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share Analysis
5.2 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
5.2.1 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
5.2.2 Europe 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis
5.2.4 Europe 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share Analysis
5.3 China HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
5.3.1 China HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
5.3.2 China 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis
5.3.4 China 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share Analysis
5.4 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
5.4.1 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
5.4.2 Japan 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis
5.4.4 Japan 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share Analysis
5.5 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
5.5.1 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
5.5.2 Southeast Asia 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis
5.5.4 Southeast Asia 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share Analysis
5.6 India HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
5.6.1 India HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
5.6.2 India 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Analysis
5.6.4 India 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share Analysis

6 Global 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Segment Market Analysis (by Type)
6.1 Global 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Sales by Type
6.2 Different Types of HPAPI (High Potency Active Pharmaceutical Ingredients) Product Interview Price Analysis
6.3 Different Types of HPAPI (High Potency Active Pharmaceutical Ingredients) Product Driving Factors Analysis
6.3.1 Innovative HPAPI Growth Driving Factor Analysis
6.3.2 Generic HPAPI Growth Driving Factor Analysis

7 Global 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Segment Market Analysis (by Application)
7.1 Global 2013-2018E HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
7.2 Different Application of HPAPI (High Potency Active Pharmaceutical Ingredients) Product Interview Price Analysis
7.3 Different Application of HPAPI (High Potency Active Pharmaceutical Ingredients) Product Driving Factors Analysis
7.3.1 Captive HPAPI of HPAPI (High Potency Active Pharmaceutical Ingredients) Growth Driving Factor Analysis
7.3.2 Merchant HPAPI of HPAPI (High Potency Active Pharmaceutical Ingredients) Growth Driving Factor Analysis

8 Major Manufacturers Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
8.1 Alkermes
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Alkermes 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Alkermes 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.2 Cambrex
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Cambrex 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Cambrex 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.3 Dishman
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Dishman 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Dishman 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.4 Dr. Reddy'S
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Dr. Reddy'S 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Dr. Reddy'S 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.5 Lonza
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Lonza 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Lonza 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.6 Novasep
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Novasep 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Novasep 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.7 Thermofisher Scientific
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Thermofisher Scientific 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Thermofisher Scientific 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.8 Pfizer
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Pfizer 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Pfizer 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.9 Merck
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Merck 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Merck 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis
8.10 Teva Pharmaceutical
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Teva Pharmaceutical 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Teva Pharmaceutical 2017 HPAPI (High Potency Active Pharmaceutical Ingredients) Business Region Distribution Analysis

9 Development Trend of Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients) Market
9.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trend Analysis
9.1.1 Global 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Price Forecast
9.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Regional Market Trend
9.2.1 North America 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast
9.2.2 Europe 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast
9.2.3 China 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast
9.2.4 Japan 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast
9.2.5 Southeast Asia 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast
9.2.6 India 2018-2025 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast
9.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trend (Product Type)
9.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trend (Application)

10 HPAPI (High Potency Active Pharmaceutical Ingredients) Marketing Type Analysis
10.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Regional Marketing Type Analysis
10.2 HPAPI (High Potency Active Pharmaceutical Ingredients) International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of HPAPI (High Potency Active Pharmaceutical Ingredients) by Region
10.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Supply Chain Analysis

11 Consumers Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

Choose License Type

Checkout Inquiry